High Energy Physics - Lattice
[Submitted on 4 Aug 2004]
Title:Simulating lattice QCD at finite temperature and zero quark mass
View PDFAbstract: We simulate lattice QCD with an irrelevant chiral 4-fermion interaction which allows us to simulate at zero quark mass. This enables us to study the finite-temperature chiral-symmetry-restoring phase transition for 2 massless quark flavours, which is believed to be second order. In particular, it enables us to estimate the critical exponents which characterize the universality class of this transition. Our earlier simulations on $N_t=4$ and $N_t=6$ lattices revealed that finite lattice-spacing artifacts on such coarse lattices affect the nature of the transition. We are now simulating on $N_t=8$ lattices ($12^3 \times 8$, $16^3 \times 8$ and $24^3 \times 8$ lattices) where we expect to expose the continuum behaviour of this transition.
References & Citations
Bibliographic and Citation Tools
Bibliographic Explorer (What is the Explorer?)
Connected Papers (What is Connected Papers?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)
Code, Data and Media Associated with this Article
alphaXiv (What is alphaXiv?)
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Hugging Face (What is Huggingface?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)
Demos
Recommenders and Search Tools
Influence Flower (What are Influence Flowers?)
CORE Recommender (What is CORE?)
arXivLabs: experimental projects with community collaborators
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.